Introduction
| DHCR24 Gene | |
|---|---|
| **Gene Symbol** | DHCR24 |
| **Full Name** | 24-Dehydrocholesterol Reductase |
| **Chromosomal Location** | 1p31.3 |
| **NCBI Gene ID** | 1719 |
| **Ensembl ID** | ENSG00000116133 |
| **UniProt ID** | Q8N0Y2 |
| **OMIM** | 606417 |
| **Protein Name** | 24-Dehydrocholesterol Reductase (DHCR24) |
| **Molecular Weight** | ~56 kDa (489 amino acids) |
| **Subcellular Localization** | Endoplasmic reticulum, lipid rafts |
| **Protein Family** | FAD-dependent oxidoreductases |
| Approach | Status |
| Small molecule activators | Research |
| Gene therapy | Preclinical |
| Cholesterol modulation | Research |
| Neuroprotective compounds | Research |
| Associated Diseases | AD, ALS, ALZHEIMER'S DISEASE, AMI, Als |
| KG Connections | 73 edges |
DHCR24 encodes 24-dehydrocholesterol reductase, a crucial enzyme in cholesterol biosynthesis with additional neuroprotective functions. This gene is important in neurodegeneration, particularly in Alzheimer’s disease and Huntington’s disease. 1DHCR24 in neurodegenerative disease (2020)Open reference
Overview
flowchart TD
DHCR24["DHCR24"] -->|"involved in"| Viral_Uptake["Viral Uptake"]
DHCR24["DHCR24"] -->|"associated with"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
DHCR24["DHCR24"] -->|"interacts with"| Alzheimer["Alzheimer"]
DHCR24["DHCR24"] -->|"interacts with"| Tumor["Tumor"]
DHCR24["DHCR24"] -->|"interacts with"| Als["Als"]
DHCR24["DHCR24"] -->|"expressed in"| Atherosclerosis["Atherosclerosis"]
DHCR24["DHCR24"] -->|"associated with"| Alzheimer["Alzheimer"]
DHCR24["DHCR24"] -->|"methylates"| Alzheimer["Alzheimer"]
DHCR24["DHCR24"] -->|"associated with"| HMGCR["HMGCR"]
DHCR24["DHCR24"] -->|"interacts with"| MAPT["MAPT"]
DHCR24["DHCR24"] -->|"interacts with"| PARP1["PARP1"]
DHCR24["DHCR24"] -->|"interacts with"| PEN2["PEN2"]
DHCR24["DHCR24"] -->|"interacts with"| PSEN1["PSEN1"]
DHCR24["DHCR24"] -->|"interacts with"| DAPK1["DAPK1"]
style DHCR24 fill:#4fc3f7,stroke:#333,color:#000DHCR24 (24-Dehydrocholesterol Reductase) encodes an enzyme involved in the final step of cholesterol biosynthesis, converting 24-dehydrocholesterol to cholesterol. Beyond its enzymatic function, DHCR24 has direct neuroprotective properties, including anti-apoptotic activity, antioxidant effects, and protection against amyloid-beta toxicity. It is highly expressed in the brain and essential for neuronal survival. 2DHCR24 and Alzheimer's disease (2019)Open reference
Gene Information
Protein Overview
Domain Structure
-
N-terminal transmembrane region: ER anchoring
-
Sterol-sensing domain: Cholesterol binding
-
FAD-binding domain: Catalytic activity
-
C-terminal region: Protein interactions
Normal Function
Cholesterol Biosynthesis
-
Catalyzes final step in cholesterol synthesis
-
Reduces 24-dehydrocholesterol to cholesterol
-
Essential for cellular membrane integrity
-
Regulates cellular cholesterol homeostasis
Neuroprotection
-
Anti-apoptotic activity via p53 inhibition
-
Antioxidant properties
-
Protects against ER stress
-
Maintains neuronal viability
Membrane Composition
-
Regulates lipid raft composition
-
Influences amyloid precursor protein processing
-
Modulates synaptic membrane properties
Disease Associations
Alzheimer’s Disease
-
DHCR24 expression reduced in AD brain
-
Cholesterol metabolism altered in AD
-
Protective against amyloid-beta toxicity
-
Genetic variants may modify AD risk
-
Lower DHCR24 correlates with cognitive decline
Huntington’s Disease
-
Mutant huntingtin affects DHCR24 function
-
Cholesterol homeostasis impaired in HD
-
Neuroprotective effects in HD models
-
Potential therapeutic target
Parkinson’s Disease
-
Altered cholesterol metabolism in PD
-
DHCR24 may protect dopaminergic neurons
-
Association with Lewy body pathology
Other Conditions
-
Desmosterolosis: DHCR24 mutations cause this rare disorder
-
Brain development: Essential for proper cortical development
-
Atherosclerosis: Role in systemic cholesterol metabolism
Expression
-
Brain regions: High expression in cortex, hippocampus, cerebellum, basal ganglia
-
Cellular expression: Neurons, astrocytes, oligodendrocytes
-
Subcellular: Endoplasmic reticulum, lipid rafts
-
Expression pattern: High in CNS, especially neurons
Therapeutic Targeting
Animal Models
-
Knockout mice: Embryonic lethal, neural-specific knockouts studied
-
Transgenic mice: Overexpression models
-
C. elegans: Cholesterol metabolism studies
-
Zebrafish: Developmental studies
Interacting Proteins
-
APP: Amyloid precursor protein processing
-
Huntingtin: Mutant HTT affects DHCR24
-
p53: DHCR24 inhibits p53-mediated apoptosis
-
SREBP: Sterol regulatory element-binding proteins
Research Directions
-
Understanding neuroprotective mechanisms
-
Developing small molecule activators
-
Gene therapy approaches
-
Biomarker development
-
Clinical translation
See Also
Background
The study of Dhcr24 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
-
PubMed - Biomedical literature
-
Alzheimer’s Disease Neuroimaging Initiative - Research data
-
Allen Brain Atlas - Brain gene expression data
References
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.